Prognostic Value of Lactate Levels in Patients With STEMI Undergoing Primary PCI

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

300 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-01-25

Study Completion Date

2022-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To assess the prognostic value of systemic arterial lactate levels in patients with ST segment elevation myocardial infarction undergoing primary PCI and correlate with the results of primary PCI and 30 days MACE follow up.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The Time Delay Correlated With LV Functions and Heart Failure Incidence in STEMI?!

NCT05097755

Myocardial Infarction

UNKNOWN

Mean Platelet Volume and STEMI Clinical Risk Scores in Prediction of Impaired Myocardial Perfusion In Acute STEMI Patients Undergoing Primary Percutaneous Coronary Intervention.

NCT04785209

No-Reflow Phenomenon

COMPLETED

LA Strain in Predicting Early Complication in STEMI After PPCI

NCT07263282

ST Elevation (STEMI) Myocardial Infarction

NOT_YET_RECRUITING

Correlation of QT Dispersion With Myocardial Perfusion in Patients With ST Elevation Myocardial Infarction Treated by Primary Per Cutaneous Coronary Intervention

NCT03269838

ST Elevation Myocardial Infarction

UNKNOWN

Ceramide Level as Apredictor of Outcomes in Patients of Anterior Myocardial Infarction Undergoing Primary Coronary Intervention

NCT04572191

Anterior STEMI

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

* Study Population: STEMI patients treated with primary PCI.
* Study period: over 6 months.
* Sample Size: 300 patients.

All patients received the standard care for acute STEMI patients which is the primary percutaneous intervention in addition to medications.

Hyperlactemia is defined as elevated lactic acid level in the blood. The normal blood lactate level is (0.5-1 mmol/L).

All subjects were subjected to

1. Careful history taking
2. Full cardiac examination
3. Investigations include:

1. 12 lead surface ECG.
2. Lactate level and full labs
3. Pre-discharge echocardiography
4. Peri-procedural details of primary PCI

the investigators assessed the relation between hyperlactemia and coronary flow, peak cardiac enzymes, hemodynamic parameters and MACE in 30 days follow up

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

STEMI

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

arterial lactate level

an arterial lactate level measured from arterial sample from STEMI patients

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient with ST-segment elevation myocardial infarction for the first time.
* Patients undergoing primary PCI.
* Adult patients ≥ 18 years old.

Exclusion Criteria

* Hemodynamically unstable patients.
* Patients with renal impairment (creatinine clearance \< 30 ml/min).
* Patients who developed flow limiting coronary dissection or mechanical complication during the procedure.
* Patients presenting \> 24 hours after symptoms onset.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No